Alnylam Pharmaceuticals
Utility Patent Applications
Last updated:
List of all Alnylam Pharmaceuticals patents 133 in total
| Status | Patent |
|---|---|
Application | Utility: BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS Filling date: 8 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: SERPIN FAMILY F MEMBER 2 (SERPINF2) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: DUAL TARGETING siRNA AGENTS Filling date: 8 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: ORAL DELIVERY OF OLIGONUCLEOTIDES Filling date: 8 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: HIGH DENSITY LIPOPROTEIN BINDING PROTEIN (HDLBP/VIGILIN) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS Filling date: 8 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS Filling date: 8 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: ENDOSOMAL CLEAVABLE LINKERS Filling date: 8 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES Filling date: 8 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS Filling date: 8 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS Filling date: 8 Sep 2025 Issue date: 14 Apr 2022 |
Application | Utility: MULTI-TARGETED SINGLE ENTITY CONJUGATES Filling date: 8 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: MODIFIED DOUBLE-STRANDED RNA AGENTS Filling date: 8 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE Filling date: 8 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF PROTEIN C (PROC) GENES Filling date: 8 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES Filling date: 8 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: MODIFIED DOUBLE STRANDED OLIGONUCLEOTIDE Filling date: 8 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: Compositions and Methods for Treating Transthyretin (TTR) Mediated Amyloidosis Filling date: 8 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE Filling date: 8 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: HEPATITIS B VIRUS (HBV) dsRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: COMPLEMENT COMPONENT C3 IRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: iRNA AGENTS WITH BIOCLEAVABLE TETHERS Filling date: 8 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: Factor XII (Hageman Factor) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), and Kininogen 1 (KNG1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: MODIFIED RNA AGENTS WITH REDUCED OFF-TARGET EFFECT Filling date: 8 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR IMPROVING STRAND BIASED Filling date: 8 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: POLYNUCLEOTIDE AGENTS TARGETING FACTOR XII (HAGEMAN FACTOR) (F12) AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: CHIRALLY-ENRICHED DOUBLE-STRANDED RNA AGENTS Filling date: 8 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR V Filling date: 8 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: GLUCOKINASE (GCK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) Filling date: 8 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: POLYNUCLEOTIDE AGENTS TARGETING ANGIOTENSINOGEN (AGT) AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 3 Jun 2021 |
Showing 1 to 50 of 133 patents.